STP 136G
Alternative Names: STP-136GLatest Information Update: 15 Sep 2022
At a glance
- Originator Sirnaomics
- Class Antihypertensives; Small interfering RNA
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Hypertension
Most Recent Events
- 06 Sep 2022 Preclinical trials in Hypertension in USA (SC) before September 2022 (Sirnaomics pipeline, September 2022)